{
    "clinical_study": {
        "@rank": "97359", 
        "acronym": "MATRIX", 
        "brief_summary": {
            "textblock": "This is an observational registry study aiming to collect data on efficacy and safety of the\n      single chamber Biotronik DX system with enhanced atrial diagnostics. The minimal follow-up\n      period is 24 months. All analyses on the data will be done post-hoc; the study does not\n      intend to confirm any pre-specified hypotheses."
        }, 
        "brief_title": "Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems", 
        "condition": [
            "Atrial Fibrillation", 
            "Tachycardia", 
            "ICD Therapy", 
            "Thromboembolic Events", 
            "Heart Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Heart Failure", 
                "Tachycardia", 
                "Thromboembolism", 
                "Embolism"
            ]
        }, 
        "detailed_description": {
            "textblock": "Enrollment / Pre-Discharge\n\n      Timing:\n\n      \u2022 At pre-hospital discharge after implantation of a BIOTRONIK Lumax 540 VR-T DX ICD with\n      Linoxsmart S DX or successor single chamber DX system according to current guidelines\n      (primary or secondary prevention)\n\n      Procedures:\n\n        -  Check inclusion and exclusion criteria\n\n        -  Patient information and written informed consent process\n\n        -  Assignment of a unique study code\n\n        -  ICD interrogation (re-programming if necessary)\n\n        -  HMSC registration (recommended)\n\n        -  Investigator assessment: appropriate atrial sensing\n\n      Documentation (note: where available the most recent assessment recorded within six months\n      prior to hospital discharge shall be considered):\n\n        -  Demographic data\n\n        -  Etiology of underlying heart disease\n\n        -  Cardiac history, symptoms (NYHA classification)\n\n        -  AF history\n\n        -  Risk factors and co-morbidities\n\n        -  Vital signs\n\n        -  Current medication (substance class)\n\n        -  LVEF (echocardiography preferred, other methods accepted if no echo available;\n           optional)\n\n        -  ECG parameters (12 lead ECG; optional)\n\n        -  History of thromboembolic events or stroke\n\n        -  Implantation\n\n      Follow-up Y1 and Y2\n\n      Timing:\n\n      \u2022 12 and 24 months (+/-2 months) after enrollment respectively\n\n      Procedures:\n\n        -  ICD interrogation / function check-up and re-programming if necessary\n\n        -  Programmer download of all data not yet submitted to BIOTRONIK according to current\n           working instruction\n\n        -  Investigator assessment: appropriate atrial sensing\n\n      Documentation (note: where available the most recent assessment recorded between the current\n      and the preceding visit shall be considered):\n\n        -  Vital signs\n\n        -  Current medication (substance class)\n\n        -  LVEF (echocardiography preferred, other methods accepted if no echo available;\n           optional)\n\n        -  ECG parameters (12 lead ECG; optional)\n\n      Event based documentation\n\n        -  New-onset or worsening AF\n\n        -  AF interventions\n\n        -  Worsening heart failure\n\n        -  Shock episode\n\n        -  Thromboembolic events (CVA, TIA, PAE)\n\n        -  Continuous surveillance / reporting of (serious) adverse events / (serious) adverse\n           device effects"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Indication for implantation of a single chamber ICD (primary or secondary prevention)\n             according to current guidelines\n\n          -  Implanted with a BIOTRONIK Lumax 540 VR-T DX ICD with Linoxsmart S DX or successor\n             single chamber DX system within 90 days prior to enrollment\n\n          -  Written informed consent, willingness and ability to comply with the protocol\n\n        Exclusion Criteria:\n\n          -  Age < 18 years\n\n          -  Any limitation to contractual capability\n\n          -  Female patients who are pregnant or breast feeding or plan a pregnancy during the\n             course of the study\n\n          -  Known active malignant disease or recovered from malignant disease within 2 years\n             prior to enrollment\n\n          -  Simultaneous participation in another study\n\n          -  Life expectancy < 2 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Patients with an indication for implantation of a single chamber ICD (primary or secondary\n        prevention) according to current guidelines and after implantation of a BIOTRONIK Lumax\n        540 VR-T DX ICD with Linoxsmart S DX or successor single chamber DX system within 90 days\n        prior to enrollment"
            }
        }, 
        "enrollment": {
            "#text": "2000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01774357", 
            "org_study_id": "TA102"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 23, 2013", 
        "location": {
            "contact": {
                "email": "holger.sigusch@hbk-zwickau.de", 
                "last_name": "Holger Sigusch, PD Dr.", 
                "phone": "+49 375 512219"
            }, 
            "facility": {
                "address": {
                    "city": "Zwickau", 
                    "country": "Germany", 
                    "zip": "08060"
                }, 
                "name": "Heinrich-Braun-Klinikum Zwickau gemeinn\u00fctzige GmbH"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX Systems", 
        "overall_contact": {
            "email": "viola.hofer@biotronik.com", 
            "last_name": "Viola Hofer, Dr.", 
            "phone": "+49 9131 8924", 
            "phone_ext": "7827"
        }, 
        "overall_contact_backup": {
            "email": "stephanie.schonegg@biotronik.com", 
            "last_name": "Stephanie Schonegg, Dr.", 
            "phone": "+49 30 68905", 
            "phone_ext": "1317"
        }, 
        "overall_official": {
            "affiliation": "Herzzentrum Leipzig, Germany", 
            "last_name": "Gerhard Hindricks, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Frequency and types of AF-related complications", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Time to occurrence of first AF-related complication", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Time to AF-related intervention after detection of de novo or worsening AF", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01774357"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Frequency and type of complications related to implantation", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Frequency and type of lead-related complications", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "All-cause mortality", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Cardiovascular hospitalization with days in hospital", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Significance of AF in acute decompensation of heart failure", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }, 
            {
                "measure": "Interventions based on Home Monitoring information regarding AF", 
                "safety_issue": "No", 
                "time_frame": "24 months"
            }
        ], 
        "source": "Biotronik SE & Co. KG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biotronik SE & Co. KG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "2 Years", 
        "verification_date": "January 2013"
    }
}